Clinical Trials Directory

Trials / Completed

CompletedNCT04125186

A Cross-Functional, Population-Representative, Web-Based, Epidemiologic Study to Estimate the Prevalence and Burden of Nocturia Due to Nocturnal Polyuria in the US

Epidemiology and Burden of Nocturia Due to Nocturnal Polyuria in the United States: The EpiNP Study

Status
Completed
Phase
Study type
Observational
Enrollment
10,190 (actual)
Sponsor
Ferring Pharmaceuticals · Industry
Sex
All
Age
30 Years
Healthy volunteers

Summary

To estimate the prevalence of nocturia due to nocturnal polyuria (NP) in the US and describe the demographic and clinical characteristics as well as the burden of illness in participants with nocturia due to NP.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBaseline EpiNP surveyThe survey takes approximately 20 to 30 minutes to complete, and consists of the following: Short Form Health Survey version 2.0 (SF-12v2.0); Lower Urinary Tract Symptoms (LUTS) Tool; Patient Perception of Bladder Condition (PPBC); Self-report Medical History and Current Medication Form; Nocturia Impact Diary (NID); Disease-Specific Healthcare-Seeking Behavior and Treatment; Epworth Sleepiness Questionnaire (ESS); Patient Reported Outcome Measurement Information System Fatigue-Short Form version 1.0 (PROMIS F-SFv1.0); Patient Health Questionnaire (PHQ-8); Work Productivity and Activity Index (WPAI-SHP); Sexual health questions; lifestyle and sociodemographic questions; additionally, only men will complete the International Prostate Symptom Score (IPSS).
DIAGNOSTIC_TESTBladder diaryIt consists of four components: measurement of waist and neck circumference, daily voiding diary (to assess voiding patterns, including frequency, volume, associated urgency, and incontinence episodes over a 24-hour period), NID (to assess nocturia impact), and assessment of morning sleepiness for 3 consecutive days and nights (including the morning of the fourth day).
DIAGNOSTIC_TESTTesting of EpiNP baseline survey, bladder diary and a qualitative interviewThis part briefly reviews the usability of the EpiNP survey and bladder diary. The feedback obtained after qualitative interview will be used to refine and finalize the instructions sent to the participants in the main part.
OTHERNo other interventionNo other intervention

Timeline

Start date
2019-07-22
Primary completion
2020-06-30
Completion
2020-06-30
First posted
2019-10-14
Last updated
2023-03-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04125186. Inclusion in this directory is not an endorsement.